|
(6) Molecular mechanisms explaining premalignant changes in the etiology of melanoma
|
1R21CA208736-01A1
|
$146,000
|
|
MURPH, MANDI
|
UNIVERSITY OF GEORGIA
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
1R01CA216248-01
|
$565,675
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
(PQ1) Cellular senescence as an initiating event in malignant transformation
|
1R21CA206013-01A1
|
$203,400
|
|
DAVID, GREGORY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers
|
5R01CA205258-02
|
$464,261
|
|
GUDAS, LORRAINE
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
|
1R01CA216273-01
|
$701,924
|
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
(PQ9)Mechanistic Role of APE1 and BER in chemotherapy-induced peripheral neuropathy
|
1R01CA205166-01A1
|
$536,312
|
|
KELLEY, MARK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
A Mechanistic Model of Chimeric Antigen Receptor (CAR) Signaling Predicts the Effects of Co-Stimulatory Signaling on T cell Activation
|
5F31CA200242-03
|
$44,044
|
|
ROHRS, JENNIFER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery
|
1R03CA216127-01
|
$77,000
|
|
YANG, YANG
|
YALE UNIVERSITY
|
|
A Novel PET Probe for Use in Cancer Diagnostics
|
2R44CA216539-02
|
$997,667
|
|
MOORE, MELISSA
|
SOFIE BIOSCIENCES, INC.
|
|
A prospective, multi-center pivotal study of the LUM Imaging System for real-time, in vivo margin assessment in breast conserving surgery
|
5R44CA211013-02
|
$937,091
|
|
LEE, W DAVID
|
LUMICELL DIAGNOSTICS, INC.
|
|
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.
|
5R01CA200795-02
|
$494,977
|
|
WESTHOFF, CAROLYN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A web-based intervention to promote follow-up care communication and functional status of Chinese immigrant breast cancer survivors
|
1R21CA212298-01A1
|
$223,390
|
|
WANG, JUDY
|
GEORGETOWN UNIVERSITY
|
|
Abnormal mitotic spindle dynamics in tumor development
|
5F30CA189673-04
|
$45,623
|
|
LARSON, MATTHEW
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Adhesive regulation during cell migration
|
5R01CA085862-18
|
$319,787
|
|
HUTTENLOCHER, ANNA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,629,581
|
$651,832
|
Rosenberg, Steven
|
CCR (NCI)
|
|
ALK causes TGF-beta insensitivity in lung cancer cells
|
5R21CA209007-02
|
$206,843
|
|
FENG, XIN-HUA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$13,582
|
$2,716
|
Kochenderfer, James
|
CCR (NCI)
|
|
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression
|
5R01CA207208-02
|
$370,575
|
|
RAMAN, VENU
|
JOHNS HOPKINS UNIVERSITY
|
|
APC and Retinoids in Zebrafish Enterocyte Development
|
5R01CA116468-13
|
$349,000
|
|
JONES, DAVID
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
|
Assessing deformable image registration in the lung using hyperpolarized-gas MRI
|
5R21CA195317-02
|
$172,765
|
|
CAI, JING
|
DUKE UNIVERSITY
|
|
Autophagy-mediated immune responses to oncolytic VSV
|
5R21CA192185-03
|
$117,072
|
|
HISCOTT, JOHN
|
ISTITUTO PASTEUR ITALIA FONDAZIONE CENCI BOLO
|
|
Balancing Efficacy and Toxicity of Intratumoral Reolysin for Diffuse Intrinsic Pontine Glioma (DIPG)
|
5F30CA210334-02
|
$44,244
|
|
SCHUELKE, MATTHEW
|
MAYO CLINIC ROCHESTER
|
|
Basic and Translational studies of Ras-mutant colorectal cancer
|
5R01CA178017-04
|
$359,556
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,562,883
|
$390,721
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Cancer and Context
|
5R35CA197571-03
|
$941,316
|
|
MACARA, IAN
|
VANDERBILT UNIVERSITY
|
|
Cancer Biology Training Grant
|
5T32CA009138-43
|
$416,373
|
|
LANGE, CAROL
|
UNIVERSITY OF MINNESOTA
|
|
Cancer Biology Training Program
|
5T32CA009673-39
|
$427,758
|
|
KAPOOR, TARUN
|
ROCKEFELLER UNIVERSITY
|
|
Cell Production Core Facility
|
ZIC BC 011569
|
$933,290
|
$466,645
|
Somerville, Robert
|
CCR (NCI)
|
|
Characterization of the SGOC metabolic network in cancer pathogenesis
|
5R01CA193256-03
|
$357,943
|
|
LOCASALE, JASON
|
DUKE UNIVERSITY
|
|
Charge sensitive optical detection for high-throughput study of small molecules
|
5R33CA202834-02
|
$389,677
|
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Circulating Biomarker Consortium for Pancreatic Cancer Early Detection
|
5U01CA210171-02
|
$794,139
|
|
WOLPIN, BRIAN
|
DANA-FARBER CANCER INST
|
|
Circulating DNA methylation biomarkers in micrometastatic breast cancer
|
1R01CA201352-01A1
|
$409,890
|
|
SALHIA, BODOUR
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$556,461
|
$556,461
|
Feldman, Steven
|
CCR (NCI)
|
|
Co-Stimulation to Enhance Adoptive Cell Therapy for Metastatic Melanoma
|
5K23CA178083-05
|
$75,778
|
|
SARNAIK, AMOD
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Collective cellular migration, cell jamming, and matrix adhesion in breast cancer model systems
|
5F32CA210447-02
|
$56,694
|
|
WANG, KARIN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
|
2R01CA154426-06A1
|
$346,690
|
|
GARRETT, WENDY
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
|
5R01CA196996-03
|
$398,025
|
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Commercializing Praedicare Dx TM platform for guiding cancer treatments
|
2R44CA203610-02A1
|
$998,807
|
|
CARDONE, MICHAEL
|
EUTROPICS PHARMACEUTICALS, INC.
|
|
Control of Apoptosis in Cancer by Survivin
|
3R01CA078810-19S1
|
$228,000
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Correlates of antitumor immunity in colorectal cancers and anti PD1 therapy
|
5R01CA203891-02
|
$374,006
|
|
HOUSSEAU, FRANCK
|
JOHNS HOPKINS UNIVERSITY
|
|
Culturally Competent Communication Intervention to Improve Latinos' Engagement in Advance Care Planning
|
1K07CA207580-01A1
|
$172,260
|
|
SHEN, MEGAN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Deciphering the Molecular Pathways Driving p53 Dependent Cell Death
|
5F32CA199716-04
|
$60,990
|
|
GUARNIERI, ANNA
|
UNIVERSITY OF COLORADO DENVER
|
|
Defining the non-myogenic origins of pediatric rhabdomyosarcoma
|
1R01CA216344-01
|
$410,606
|
|
HATLEY, MARK
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility
|
1UH2CA216432-01
|
$354,168
|
|
ROYCHOWDHURY, SAMEEK
|
OHIO STATE UNIVERSITY
|
|
Developing differentiation therapy for the treatment of patients with acute myeloid leukemia
|
1K08CA201640-01A1
|
$169,268
|
|
SYKES, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu
|
5R01CA188323-04
|
$321,625
|
|
WANG, SHAOMENG
|
UNIVERSITY OF MICHIGAN
|
|
Development of a Multimodal Deep Learning Model for the Generation of Cancer Probability Maps and Imaging Biomarkers for Prostate Cancer using Multiparametric MRI
|
5F30CA210329-02
|
$37,542
|
|
SARMA, KARTHIK
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Development of a novel therapeutic agent that exploits specific vulnerabilities in claudin low breast cancer
|
1R01CA207222-01A1
|
$351,544
|
|
SINGH, RAVI
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Development of Anatomical Patient Models to Facilitate MR-only Treatment Planning
|
5R01CA204189-02
|
$304,836
|
|
GLIDE-HURST, CARRI
|
Henry Ford Health System
|
|
Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis
|
1R01CA207680-01A1
|
$440,344
|
|
DERMARDIROSSIAN, CELINE
|
SCRIPPS RESEARCH INSTITUTE
|
Total relevant funding to Gene Therapy Clinical Trials for this search: $6,605,745
|